Amanote Research

Amanote Research

    RegisterSign In

Beyond TNF: TNF Superfamily Cytokines as Targets for the Treatment of Rheumatic Diseases

Nature Reviews Rheumatology - United Kingdom
doi 10.1038/nrrheum.2017.22
Full Text
Open PDF
Abstract

Available in full text

Categories
Rheumatology
Date

March 9, 2017

Authors
Michael CroftRichard M. Siegel
Publisher

Springer Science and Business Media LLC


Related search

TNF-alpha Inhibitor-Induced Infections in Rheumatic Diseases

The Journal of Turkish Family Physician
2018English

Structural Basis of Signal Transduction in the TNF Receptor Superfamily

Advances in Immunology
2013English

How the Discovery of TNF-α Has Advanced Gastrointestinal Diseases and Treatment Regimes

Digestive Diseases and Sciences
PhysiologyGastroenterology
2014English

A Population-Based Study of Tuberculosis Incidence Among Rheumatic Disease Patients Under Anti-TNF Treatment

PLoS ONE
Multidisciplinary
2019English

Looking Beyond Death: A Morphogenetic Role for the TNF Signalling Pathway

Journal of Cell Science
Cell Biology
2009English

Histone Deacetylases as Targets for Treatment of Multiple Diseases

Clinical Science
Medicine
2013English

The Tumor Necrosis Factor Superfamily of Cytokines in the Inflammatory Myopathies: Potential Targets for Therapy

Clinical and Developmental Immunology
2012English

Tocilizumab: Is There Life Beyond Anti-TNF Blockade?

International Journal of Clinical Practice
Medicine
2011English

Fas Ligand (TNF Superfamily, Member 6; FASL); VEGF-A; Cyclooxygenase (COX)

Science-Business eXchange
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy